Health In Tech, Inc. Class A Common Stock (HIT) — Capital Reinvestment Ratio

Latest as of December 2025: 1.84x

Health In Tech, Inc. Class A Common Stock (HIT) has a Capital Reinvestment Ratio of 1.84x as of December 2025, meaning it reinvests 2% of its operating cash flow ($451.21K) in capital expenditures ($831.71K). Check HIT goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.84x
Capex / Operating Cash Flow

Operating Cash Flow

$451.21K
USD

Capital Expenditures

$831.71K
USD

Data as of

Dec 2025
Most recent filing

Health In Tech, Inc. Class A Common Stock Capital Reinvestment Ratio (2022–2025)

This chart tracks Health In Tech, Inc. Class A Common Stock's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Health In Tech, Inc. Class A Common Stoc.

Annual Capital Reinvestment Ratio for Health In Tech, Inc. Class A Common Stock (2022–2025)

Year-by-year Capital Reinvestment Ratio for Health In Tech, Inc. Class A Common Stock from 2022 to 2025. See Health In Tech, Inc. Class A Common Stoc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 1.02x $3.13 Million $3.19 Million ▲ +145.9%
2024 0.41x $2.18 Million $900.75K ▼ -44.7%
2023 0.75x $1.53 Million $1.14 Million ▼ -52.0%
2022 1.56x $782.75K $1.22 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow